Joseph Proietto
Endocrine Specialist Centre, VIC, Australia
- This delegate is presenting an abstract at this event.
Professor Proietto is the inaugural Sir Edward Dunlop Medical Research Foundation, Professor of Medicine, in the Department of Medicine Austin Health, University of Melbourne. Professor Proietto is a scientist and clinician investigating the genetic and biochemical causes of obesity and type 2 diabetes. He established one of the first obesity clinics in a Victorian public hospital at the Royal Melbourne Hospital. Since moving to the Heidelberg Repatriation Hospital he has established the Weight Control Clinic at Austin Health. He is a past president of the Australasian Society for the Study of Obesity and was the Chair of the Program Organising Committee for the 10th International Congress of Obesity Sydney. He has been on the Council of the Australian Diabetes Society and has served on the Board of Diabetes Australia acting as Chairman of its Medical Educational and Scientific Council. He was Chairman of the National Association of Diabetes Centre. Professor Proietto has published over 170 articles, book chapters and books on obesity and diabetes. He is an editor and reviewer of a number of international scientific journals.
Presentations this author is a contributor to:
Improved glycaemic control without increased hypoglycaemia incidence and weight gain with insulin-vildagliptin combination therapy in Asian patients with type 2 diabetes (#81)
5:00 PM
Richard Simpson
ADS Clinical Orals - Therapies
Partial deletion of the selenoprotein SEPS1 in β-cells leads to impairment in insulin secretion (#168)
9:30 AM
Steve Weng
ADS Basic Orals - Mission Impossible: Can We Save the Islet Beta Cell?
Optimization of conditional glycogen synthase deletion in skeletal muscle in mice. (#291)
1:30 PM
Chrysovalantou E. Xirouchaki
ADS Basic Poster Discussions
Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes (#76)
5:00 PM
Pierre Scotney
ADS Basic Orals - Insulin Resistance: How to Cause it and How to Treat it
Glucotoxicity specifically impairs second-phase insulin secretion in an obese transgenic rat model (#143)
4:00 PM
Christos N Joannides
ADS Pincus Taft Young Investigators Award Session